These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 12108310)

  • 1. [Prospective regional study of an epidemic of respiratory syncytial virus (RSV) bronchiolitis].
    Grimaldi M; Cornet B; Milou C; Gouyon JB
    Arch Pediatr; 2002 Jun; 9(6):572-80. PubMed ID: 12108310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use.
    Prais D; Schonfeld T; Amir J;
    Pediatrics; 2003 Sep; 112(3 Pt 1):548-52. PubMed ID: 12949282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum palivizumab level is associated with decreased severity of respiratory syncytial virus disease in high-risk infants.
    Forbes ML; Kumar VR; Yogev R; Wu X; Robbie GJ; Ambrose CS
    Hum Vaccin Immunother; 2014; 10(10):2789-94. PubMed ID: 25483663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia.
    Grimaldi M; Gouyon B; Michaut F; Huet F; Gouyon JB;
    Pediatr Infect Dis J; 2004 Dec; 23(12):1081-5. PubMed ID: 15626942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of clinical scoring systems in infants with bronchiolitis admitted to the intensive care unit.
    Rödl S; Resch B; Hofer N; Marschitz I; Madler G; Eber E; Zobel G
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2667-72. PubMed ID: 22526870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins.
    Dotan M; Ashkenazi-Hoffnung L; Samra Z; Livni G; Yarden-Bilavsky H; Amir J; Bilavsky E
    Isr Med Assoc J; 2013 Nov; 15(11):701-4. PubMed ID: 24511652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Perinatal history and hospitalization for bronchiolitis. A comparison with the impact-RSV Study Group].
    Bonillo Perales A ; DíezDelgado Rubio J ; Ortega Montes A ; Infante Márquez P ; Jiménez Liria M ; Batlles Garrido J ; López Muñoz J
    An Esp Pediatr; 2000 Dec; 53(6):527-32. PubMed ID: 11148149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoprophylaxis with palivizumab in Andalusia (Spain). Results of the 2000-2001 respiratory syncytial virus epidemic].
    Grupo de Hospitales Benazuza
    An Esp Pediatr; 2002 Apr; 56(4):293-7. PubMed ID: 11927095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001-2005).
    Berger TM; Aebi C; Duppenthaler A; Stocker M;
    Infection; 2009 Apr; 37(2):109-16. PubMed ID: 19412586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of a retrospective survey and evaluation of the validity of a medical information system programme.
    Soilly AL; Ferdynus C; Desplanches O; Grimaldi M; Gouyon JB
    Epidemiol Infect; 2012 Apr; 140(4):608-16. PubMed ID: 21733254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asthma risk after a pediatric intensive care unit admission for respiratory syncytial virus bronchiolitis.
    Be'er M; Bushmitz S; Cahal M; Sadot E; Yochpaz S; Besor O; Amirav I; Lavie M
    Pediatr Pulmonol; 2022 Jul; 57(7):1677-1683. PubMed ID: 35579122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey.
    Prais D; Danino D; Schonfeld T; Amir J
    Chest; 2005 Oct; 128(4):2765-71. PubMed ID: 16236953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
    Romero JR
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does weight influence the course of RSV bronchiolitis in hospitalized infants?
    Tamir S; Golan-Tripto I; Hazan I; Adar A; Burrack N; Cohen B; Goldbart AD; Geva N
    Eur J Pediatr; 2024 Jun; 183(6):2663-2669. PubMed ID: 38507064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of hospitalization for acute bronchiolitis in children: differences between RSV and non-RSV bronchiolitis.
    Hervás D; Reina J; Yañez A; del Valle JM; Figuerola J; Hervás JA
    Eur J Clin Microbiol Infect Dis; 2012 Aug; 31(8):1975-81. PubMed ID: 22240853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palivizumab efficacy in preterm infants with gestational age < or = 30 weeks without bronchopulmonary dysplasia.
    Grimaldi M; Gouyon B; Sagot P; Quantin C; Huet F; Gouyon JB;
    Pediatr Pulmonol; 2007 Mar; 42(3):189-92. PubMed ID: 17243184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for respiratory syncytial virus bronchiolitis hospitalizations in children with chronic diseases.
    Shmueli E; Goldberg O; Mei-Zahav M; Stafler P; Bar-On O; Levine H; Steuer G; Mussaffi H; Gendler Y; Blau H; Prais D
    Pediatr Pulmonol; 2021 Jul; 56(7):2204-2211. PubMed ID: 33913611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations.
    Bennett MV; McLaurin K; Ambrose C; Lee HC
    PLoS One; 2018; 13(10):e0205399. PubMed ID: 30379957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece.
    Tsolia MN; Kafetzis D; Danelatou K; Astral H; Kallergi K; Spyridis P; Karpathios TE
    Eur J Epidemiol; 2003; 18(1):55-61. PubMed ID: 12705624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.